Detalles de la búsqueda
1.
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
Lancet
; 388(10063): 2997-3005, 2016 12 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27908454
2.
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.
Breast Cancer Res
; 18(1): 67, 2016 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27349747
3.
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
Lancet Oncol
; 16(1): 25-35, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25524798
4.
Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non-small-cell lung cancer.
BMC Cancer
; 15: 339, 2015 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25929582
5.
Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer.
BMC Cancer
; 14: 290, 2014 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-24766732
6.
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
; 6(4): e235822, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37022687
7.
Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy.
Springerplus
; 4: 316, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26155455
8.
Efficacy and safety of balugrastim compared with pegfilgrastim in patients with breast cancer receiving chemotherapy.
Clin Breast Cancer
; 14(2): 101-8, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24485296
9.
First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.
J Clin Oncol
; 30(9): 921-9, 2012 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22331954
Resultados
1 -
9
de 9
1
Próxima >
>>